Oxford Capital related stories
All articles and analysis
- Intent HQ gets funding led by Oxford Capital
Specialist UK-based growth capital investor, Oxford Capital, has led an investment in London-based software company, Intent HQ. Oxford Capital joins existing investor, Edge Performance VCT.
- Oxford Capital backs Arkivum
Arkivum has secured 1.9 million pounds in financing. Oxford Capital led the round with participation from return backers IP Group and Parkwalk Advisors. Based in the UK, Arkivum is a provider of digital archiving solutions.
- Oxford Capital backs Arkivum
Arkivum has secured 1.9 million pounds in financing. Oxford Capital led the round with participation from return backers IP Group and Parkwalk Advisors. Based in the UK, Arkivum is a provider of digital archiving solutions.
European people briefs, compiled for April 2014Corporate COO goes VC; New execs at Oxford; three join small-biz investor
- Oxford Capital appoints infrastructure investment director
Oxford Capital has appointed Barney Rhys Jones as infrastructure investment director. He will manage Oxford Capital’s renewable energy and infrastructure asset portfolio and operational aspects of the investment management process.
- Oxford Capital leads Linkdex funding round
Growth capital investor Oxford Capital has led a major funding round for Linkdex. Oxford Capital joins existing investor Amadeus Capital which backed the business from an early stage. Based in London and New York Linkdex is a web-based, enterprise platform for search engine optimisation (SEO), PR, social, content marketing and business intelligence.
- Green Biologics raises Series B led by Sofinnova
UK-based Green Biologics has raised a $25 million Series B round led by Sofinnova Partners. Morgan Joseph TriArtisan was exclusive financial advisor to the company.
- Sofinnova Partners leads Series B round for Green Biologics
Green Biologics Ltd said Monday that it has received £15.4 million in Series B funding. Sofinnova Partners led the round with participation from Swire Pacific Limited, Capricorn Venture Partners, Oxford Capital Partners, Morningside Ventures and ConvergInce Holdings. Based in the UK, Green Biologics is a industrial biotechnology company.
- Oxford Capital Exits Arieso in $85m Deal
Specialist growth capital investor Oxford Capital has exited mobile network optimisation business, Arieso, in an $85 million deal. The sale realised returns of up to 4.7x for investors.
- Glide Pharma Adds $21.4M
Oxford, England-based Glide Pharma raised $21.4 million in new funding. The company, a pharmaceutical development and device company, is backed by investors including Invesco Perpetual. Glide Pharma will use the funds for manufacturing of its solid dose injector system.